Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery

NARecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 8, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Wound Healing After MMS SurgeryBCC - Basal Cell CarcinomaSCC - Squamous Cell CarcinomaMelanoma In Situ
Interventions
DEVICE

A microsurfaced ADM (acellular dermal matrix)

X A-DERM™ ADM has been resurfaced (Microsurfaced) instead of currently utilized smooth surface reconstructive grafts. Microsurfacing of regenerative tissue grafts increases the surface area at the graft-to-host interface and results in quicker absorption of blood into the graft, greater cellular infiltration, improved seal and wound bed preparedness.

Trial Locations (1)

75032

RECRUITING

Bare Dermatology, Rockwall

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

CellTherX

INDUSTRY

lead

McGuire Institute

INDUSTRY